These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24261758)

  • 21. Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeks.
    Takahashi N; Kojima T; Kaneko A; Kida D; Hirano Y; Fujibayashi T; Yabe Y; Takagi H; Oguchi T; Miyake H; Kato T; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Asai S; Yoshioka Y; Takemoto T; Terabe K; Asai N; Ishiguro N
    J Rheumatol; 2015 May; 42(5):786-93. PubMed ID: 25834204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study.
    Buch MH; Hensor EM; Rakieh C; Freeston JE; Middleton E; Horton S; Das S; Peterfy C; Tan AL; Wakefield RJ; Emery P
    Rheumatology (Oxford); 2017 Jan; 56(1):58-67. PubMed ID: 28028155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
    Genovese MC; Schiff M; Luggen M; Becker JC; Aranda R; Teng J; Li T; Schmidely N; Le Bars M; Dougados M
    Ann Rheum Dis; 2008 Apr; 67(4):547-54. PubMed ID: 17921185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
    Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).
    Takeuchi T; Yamanaka H; Inoue E; Nagasawa H; Nawata M; Ikari K; Saito K; Sekiguchi N; Sato E; Kameda H; Iwata S; Mochizuki T; Amano K; Tanaka Y
    Mod Rheumatol; 2008; 18(5):447-54. PubMed ID: 18493716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).
    Sugihara T; Ishizaki T; Hosoya T; Iga S; Yokoyama W; Hirano F; Miyasaka N; Harigai M
    Rheumatology (Oxford); 2015 May; 54(5):798-807. PubMed ID: 25296748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.
    Baker JF; Conaghan PG; Emery P; Baker DG; Østergaard M
    Ann Rheum Dis; 2016 Jun; 75(6):1114-9. PubMed ID: 26091907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study.
    Sekiguchi M; Fujii T; Matsui K; Murakami K; Morita S; Ohmura K; Kawahito Y; Nishimoto N; Mimori T; Sano H;
    J Rheumatol; 2016 Nov; 43(11):1974-1983. PubMed ID: 27585689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry.
    Gottenberg JE; Ravaud P; Cantagrel A; Combe B; Flipo RM; Schaeverbeke T; Houvenagel E; Gaudin P; Loeuille D; Rist S; Dougados M; Sibilia J; Le Loët X; Marcelli C; Bardin T; Pane I; Baron G; Mariette X
    Ann Rheum Dis; 2012 Nov; 71(11):1815-9. PubMed ID: 22615458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.
    Nüßlein HG; Alten R; Galeazzi M; Lorenz HM; Boumpas D; Nurmohamed MT; Bensen WG; Burmester GR; Peter HH; Rainer F; Pavelka K; Chartier M; Poncet C; Rauch C; Bars ML
    BMC Musculoskelet Disord; 2014 Jan; 15():14. PubMed ID: 24410774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
    Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
    Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan.
    Takeuchi T; Matsubara T; Ohta S; Mukai M; Amano K; Tohma S; Tanaka Y; Yamanaka H; Miyasaka N
    Rheumatology (Oxford); 2015 Apr; 54(4):683-91. PubMed ID: 25257039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model.
    de Punder YM; Jansen TL; van Ede AE; den Broeder AA; van Riel PL; Fransen J
    J Rheumatol; 2015 Mar; 42(3):398-404. PubMed ID: 25593241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of abatacept in rheumatoid arthritis.
    von Kempis J; Dudler J; Hasler P; Kyburz D; Tyndall A; Zufferey P; Villiger PM
    Swiss Med Wkly; 2012; 142():w13581. PubMed ID: 22581564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine.
    de Punder YM; van Riel PL; Fransen J
    J Rheumatol; 2015 Mar; 42(3):391-7. PubMed ID: 25593237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of abatacept in patients with rheumatoid arthritis, as assessed by magnetic resonance imaging of bilateral hands.
    Kukida Y; Kasahara A; Seno T; Inoue T; Sagawa R; Kida T; Nakabayashi A; Nagahara H; Murakami K; Sugitani T; Morita S; Ito H; Oda R; Fujiwara H; Kohno M; Kawahito Y
    Int J Rheum Dis; 2018 Sep; 21(9):1678-1685. PubMed ID: 28730687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.